News

  • In this month’s Pharmacy SIG Literature Update:  PTCy versus ATG for GVHD prophylaxis, cost and outcomes with once-daily busulfan dosing, carfilzomib for the treatment of chronic GVHD and much more! Literature summaries are provided as information ...

  • Please join us for the ASTCT Pharmacy SIG November Journal Club on PD-1 Blockade post HSCT and the Dosing of Conditioning Regimens in Obese Patients on Wednesday, Nov. 20, 2019 at 2:00 pm CST. Our presenters are: Gretchen Junker, PharmD , PGY2 ...

  • Since ASTCT’s founding in 1993, one of the most important aspects of the society has been connectivity. In the 25+ years since, we’ve seen the society grow and change. But one thing remains true: the society’s dedication to helping those in BMT and cellular ...

  • When Dr. John DiPersio looked around at his colleagues—people who were integral parts of the cellular therapy and BMT team, ranging from nurses and PAs to physicians—he realized something that concerned him: Not all were members of ASTCT. The former ...

  • Mikaela VanMoorleghem, Education and Training Coordinator Foundation for the Accreditation of Cellular Therapy Data Audit Policy Update FACT-JACIE Standards for Hematopoietic Cellular Therapy require that accredited clinical programs keep ...